These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 12478470)
1. Differential subcellular localization of functionally divergent survivin splice variants. Mahotka C; Liebmann J; Wenzel M; Suschek CV; Schmitt M; Gabbert HE; Gerharz CD Cell Death Differ; 2002 Dec; 9(12):1334-42. PubMed ID: 12478470 [TBL] [Abstract][Full Text] [Related]
2. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797 [TBL] [Abstract][Full Text] [Related]
3. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Rodríguez JA; Span SW; Ferreira CG; Kruyt FA; Giaccone G Exp Cell Res; 2002 Apr; 275(1):44-53. PubMed ID: 11925104 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer. Atlasi Y; Mowla SJ; Ziaee SA Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel nucleolar localization signal and a degradation signal in Survivin-deltaEx3: a potential link between nucleolus and protein degradation. Song Z; Wu M Oncogene; 2005 Apr; 24(16):2723-34. PubMed ID: 15735764 [TBL] [Abstract][Full Text] [Related]
6. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas. Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Meng H; Lu C; Mabuchi H; Tanigawa N Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590 [TBL] [Abstract][Full Text] [Related]
8. Exonization of Alu-generated splice variants in the survivin gene of human and non-human primates. Mola G; Vela E; Fernández-Figueras MT; Isamat M; Muñoz-Mármol AM J Mol Biol; 2007 Mar; 366(4):1055-63. PubMed ID: 17204284 [TBL] [Abstract][Full Text] [Related]
9. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia. Tröger A; Siepermann M; Mahotka C; Wethkamp N; Bülle H; Laws HJ; Escherich G; Janka-Schaub G; Göbel U; Dilloo D Klin Padiatr; 2007; 219(3):127-33. PubMed ID: 17525905 [TBL] [Abstract][Full Text] [Related]
10. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N Urol J; 2009; 6(2):101-8. PubMed ID: 19472128 [TBL] [Abstract][Full Text] [Related]
11. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736 [TBL] [Abstract][Full Text] [Related]
12. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer. Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia. Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902 [TBL] [Abstract][Full Text] [Related]
14. Distinct expression of Survivin splice variants in breast carcinomas. Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334 [TBL] [Abstract][Full Text] [Related]
15. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies. Caldas H; Honsey LE; Altura RA Mol Cancer; 2005 Mar; 4(1):11. PubMed ID: 15743529 [TBL] [Abstract][Full Text] [Related]
16. Survivin splice variants regulate the balance between proliferation and cell death. Caldas H; Jiang Y; Holloway MP; Fangusaro J; Mahotka C; Conway EM; Altura RA Oncogene; 2005 Mar; 24(12):1994-2007. PubMed ID: 15688031 [TBL] [Abstract][Full Text] [Related]
17. An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy. Zhu N; Gu L; Findley HW; Li F; Zhou M Oncogene; 2004 Sep; 23(45):7545-51. PubMed ID: 15334064 [TBL] [Abstract][Full Text] [Related]
18. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax. Temme A; Rodriguez JA; Hendruschk S; Günes S; Weigle B; Schäkel K; Schmitz M; Bachmann M; Schackert G; Rieber EP Cancer Lett; 2007 Jun; 250(2):177-93. PubMed ID: 17084966 [TBL] [Abstract][Full Text] [Related]
19. Roles of survivin isoforms in the chemopreventive actions of NSAIDS on colon cancer cells. Mandayam S; Huang R; Tarnawski AS; Chiou SK Apoptosis; 2007 Jun; 12(6):1109-16. PubMed ID: 17151952 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of survivin splice isoforms in medulloblastomas. Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]